Calumet, Inc. (CLMT) is an Indianapolis-based manufacturer of specialty hydrocarbon products — lubricating oils, waxes, solvents and asphalt — that also owns Montana Renewables, one of only a handful of commercial-scale sustainable aviation fuel producers in North America. The stock fell 6.47% to $29.76 in Wednesday's session, down from Tuesday's close of $31.82. The direction was decisively lower, driven chiefly by a sector-wide de-rating of refiners as product margins narrow, with a same-day price-target cut adding pressure on a name already digesting a reworked capital structure at its renewables subsidiary.
The dominant force behind Wednesday's move was not company-specific. U.S. refiners traded sharply lower as the benchmark 3-2-1 crack spread — the margin earned converting crude into gasoline and diesel — continued to slide, falling roughly 36% over six weeks from about $65.56 a barrel in early October to near $41.90. That compression reflects recovering Gulf Coast crude supply and rebuilt product inventories after the summer's supply shock, which has pulled the group well off September records despite still-strong absolute margins.
Calumet is highly sensitive to that trend. Its Specialty Products and Solutions unit and its Montana refining complex both benefited from the margin windfall in the third quarter, and investors are now marking down the durability of those earnings. CLMT fell harder than VLO but broadly in line with smaller, more leveraged peers, a pattern consistent with high-beta exposure to refining sentiment.
On Wednesday morning, TD Cowen maintained a Hold rating on Calumet while lowering its price target to $37 from $40, a 7.5% reduction. Even after the cut, the target still sits more than 20% above the current share price, and the change did not alter the firm's neutral stance. The revision is best read as a recalibration of earnings power in a softer margin environment rather than an outright negative call, but on a day when the entire group was under pressure it reinforced the bearish tone and gave sellers a reason to press positions.
Calumet disclosed on Nov. 5 an amended agreement with Warburg Pincus covering Montana Renewables. Under the revised structure, the private equity firm exchanged its 13.17% equity interest for warrants on up to 8% of the subsidiary above a $750 million equity value, while its preferred units grew to roughly $395 million and the promised annual return rose to 11.5% from 8%. Calumet, in turn, moved to 100% ownership of the plant's ordinary equity and secured a $30 million annual lease payment from the asset redeployment underpinning its MaxSAF expansion.
Management framed the deal as a capital-efficient simplification that saves about $1 billion versus the original expansion plan. The market has read it more cautiously, focusing on the larger, more expensive claim sitting ahead of common equity in an unrestricted subsidiary. That interpretive gap has kept a lid on the shares well before today.
Volume was running above the stock's three-month average daily pace of roughly 1.48 million shares, though not dramatically so in the early going, pointing to steady institutional selling rather than a disorderly flush. The move aligned tightly with the refining complex but diverged from the broad market, where the SPY was little changed and the XLE energy ETF fell a comparatively modest 1.66%.
Technically, the decline broke through the November lows and pushed the stock to its lowest level since mid-May, leaving shares roughly 50% below the 52-week high of $59.87 set on Sept. 21 and decisively under their intermediate moving averages. The session's range of roughly $29.57 to $31.58 marked a clear failure to hold the $31 area that had supported prices for several sessions.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. Calumet's score is 26 out of 100.
The verified news was modest: a price-target cut with no rating change, layered on top of a sector-wide margin de-rating that is generic rather than company-specific. The price move was moderately unusual — about 2.5 times the stock's typical daily swing of roughly 2.6% over the past three months — but comparable or larger declines occurred six times in the last 60 sessions, so it is not a statistical outlier. Weak news and a familiar-sized move combine to a low score.
Attention turns to fourth-quarter guidance execution. Management has flagged lower Shreveport specialty volumes from the October turnaround and improved Montana Renewables margins as the SAF mix rises, with the MaxSAF tie-in work completing around the end of November. Weekly inventory data and the trajectory of distillate cracks will shape the sector tone into year-end, while the February earnings report will be the first to consolidate the amended Warburg structure. Key risks include a faster normalization of specialty and renewable margins, leverage near $2.2 billion of debt, and the recurring question of how much value ultimately accrues to common shareholders after preferred obligations.
Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. Bots differ by strategy, timeframe, performance metrics and the symbols they trade, so the page gives traders a practical way to compare live approaches side by side. Reviewing the current leaders is a sensible next step for anyone weighing how automation fits their own process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLMT advanced for three days, in 262 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
CLMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLMT as a result. In 51 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for CLMT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
CLMT moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLMT crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLMT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for CLMT entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.064) is normal, around the industry mean (2.284). P/E Ratio (-25.740) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (1.548). Dividend Yield (0.069) settles around the average of (0.039) among similar stocks. P/S Ratio (1.100) is also within normal values, averaging (48.960).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. CLMT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of specialty hydrocarbon products
Industry ChemicalsSpecialty